Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses.
Reshamwala D, Shroff S, Sheik Amamuddy O, Laquintana V, Denora N, Zacheo A, Lampinen V, Hytonen VP, Tastan Bishop Ö, Krol S, Marjomäki V. Reshamwala D, et al. Among authors: marjomaki v. Pharmaceutics. 2021 Jul 31;13(8):1182. doi: 10.3390/pharmaceutics13081182. Pharmaceutics. 2021. PMID: 34452144 Free PMC article.
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months.
Pelliccia M, Andreozzi P, Paulose J, D'Alicarnasso M, Cagno V, Donalisio M, Civra A, Broeckel RM, Haese N, Jacob Silva P, Carney RP, Marjomäki V, Streblow DN, Lembo D, Stellacci F, Vitelli V, Krol S. Pelliccia M, et al. Among authors: marjomaki v. Nat Commun. 2016 Nov 30;7:13520. doi: 10.1038/ncomms13520. Nat Commun. 2016. PMID: 27901019 Free PMC article.
A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses.
Saarinen NVV, Laiho JE, Richardson SJ, Zeissler M, Stone VM, Marjomäki V, Kantoluoto T, Horwitz MS, Sioofy-Khojine A, Honkimaa A, Hankaniemi MM, Flodström-Tullberg M, Hyöty H, Hytönen VP, Laitinen OH. Saarinen NVV, et al. Among authors: marjomaki v. Sci Rep. 2018 Jan 8;8(1):33. doi: 10.1038/s41598-017-18495-4. Sci Rep. 2018. PMID: 29311608 Free PMC article.
Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications.
Linnakoski R, Reshamwala D, Veteli P, Cortina-Escribano M, Vanhanen H, Marjomäki V. Linnakoski R, et al. Among authors: marjomaki v. Front Microbiol. 2018 Oct 2;9:2325. doi: 10.3389/fmicb.2018.02325. eCollection 2018. Front Microbiol. 2018. PMID: 30333807 Free PMC article. Review.
Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.
Turkki P, Laajala M, Stark M, Vandesande H, Sallinen-Dal Maso H, Shroff S, Sävneby A, Galitska G, Lindberg AM, Marjomäki V. Turkki P, et al. Among authors: marjomaki v. J Virol. 2019 Sep 30;93(20):e01130-19. doi: 10.1128/JVI.01130-19. Print 2019 Oct 15. J Virol. 2019. PMID: 31375587 Free PMC article.
A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
Hankaniemi MM, Stone VM, Sioofy-Khojine AB, Heinimäki S, Marjomäki V, Hyöty H, Blazevic V, Laitinen OH, Flodström-Tullberg M, Hytönen VP. Hankaniemi MM, et al. Among authors: marjomaki v. Vaccine. 2019 Sep 20;37(40):5962-5971. doi: 10.1016/j.vaccine.2019.08.037. Epub 2019 Aug 27. Vaccine. 2019. PMID: 31471148 Free article.
Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine.
Hankaniemi MM, Stone VM, Andrejeff T, Heinimäki S, Sioofy-Khojine AB, Marjomäki V, Hyöty H, Blazevic V, Flodström-Tullberg M, Hytönen VP, Laitinen OH. Hankaniemi MM, et al. Among authors: marjomaki v. Antiviral Res. 2019 Nov;171:104595. doi: 10.1016/j.antiviral.2019.104595. Epub 2019 Sep 3. Antiviral Res. 2019. PMID: 31491431 Free article.
115 results